8th Cir. Reverses Summary Judgment for Lilly in Cymbalta Suicide Case

ST. LOUIS — A federal appeals court has reversed a grant of summary judgment to Eli Lilly & Co. in a Cymbalta suicide case, finding issues of fact as to whether the prescribing doctor was aware that the drug could cause suicidal thoughts in adolescents. Schilf, et ux., v. Eli Lilly & Co., No. 11-2082 (8th Cir.).

On Aug. 3, the 8th Circuit U.S. Court of Appeals also found a question of fact as to whether the physician would have prescribed Cymbalta if he was provided information about clinical trial suicides or any causal role for Cymbalta in inducing suicidality.